NO177794C - Fremgangsmåte for fremstilling av et fusjonsprotein, samt nukleinsyre, ekspresjonsvektor og vertscelle som kan anvendes ved fremgangsmåten - Google Patents

Fremgangsmåte for fremstilling av et fusjonsprotein, samt nukleinsyre, ekspresjonsvektor og vertscelle som kan anvendes ved fremgangsmåten

Info

Publication number: NO177794C
Authority: NO; Norway
Prior art keywords: preparation; nucleic acid; well; host cell; fusion protein
Prior art date: 1986-11-01

Application number

NO882918A

Other languages

English (en)

Norwegian (no)

Other versions

NO882918L (no

NO177794B (no

NO882918D0 (no

Inventor

Alan John Kingsman

Susan Mary Kingsman

Sally Elizabeth Adams

Original Assignee

British Bio Technology

Oxford Gene Systems Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-11-01

Filing date

1988-06-30

Publication date

1995-11-22

1986-11-01 Priority claimed from GB868626148A external-priority patent/GB8626148D0/en

1987-04-09 Priority claimed from GB878708532A external-priority patent/GB8708532D0/en

1988-06-30 Application filed by British Bio Technology, Oxford Gene Systems Ltd filed Critical British Bio Technology

1988-06-30 Publication of NO882918D0 publication Critical patent/NO882918D0/no

1988-08-29 Publication of NO882918L publication Critical patent/NO882918L/no

1995-08-14 Publication of NO177794B publication Critical patent/NO177794B/no

1995-11-22 Publication of NO177794C publication Critical patent/NO177794C/no

Links

239000013604 expression vector Substances 0.000 title 1
108020001507 fusion proteins Proteins 0.000 title 1
102000039446 nucleic acids Human genes 0.000 title 1
108020004707 nucleic acids Proteins 0.000 title 1
150000007523 nucleic acids Chemical class 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
- C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
- C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Genetics & Genomics (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Biomedical Technology (AREA)
Wood Science & Technology (AREA)
Biotechnology (AREA)
General Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Molecular Biology (AREA)
Zoology (AREA)
General Health & Medical Sciences (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Mycology (AREA)
Microbiology (AREA)
Plant Pathology (AREA)
Physics & Mathematics (AREA)
Medicinal Chemistry (AREA)
Virology (AREA)
Oncology (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
Gastroenterology & Hepatology (AREA)
Public Health (AREA)
Communicable Diseases (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

NO882918A 1986-11-01 1988-06-30 Fremgangsmåte for fremstilling av et fusjonsprotein, samt nukleinsyre, ekspresjonsvektor og vertscelle som kan anvendes ved fremgangsmåten NO177794C (no)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
GB868626148A GB8626148D0 (en)	1986-11-01	1986-11-01	Antigen presentation & purification system
GB878708532A GB8708532D0 (en)	1987-04-09	1987-04-09	Particulate hybrid hiv antigens
US3688887A	1987-04-10	1987-04-10
PCT/GB1987/000763 WO1988003562A1 (en)	1986-11-01	1987-10-28	Particulate hybrid hiv antigens

Publications (4)

Publication Number	Publication Date
NO882918D0 NO882918D0 (no)	1988-06-30
NO882918L NO882918L (no)	1988-08-29
NO177794B NO177794B (no)	1995-08-14
NO177794C true NO177794C (no)	1995-11-22

Family

ID=27263195

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO882918A NO177794C (no)	1986-11-01	1988-06-30	Fremgangsmåte for fremstilling av et fusjonsprotein, samt nukleinsyre, ekspresjonsvektor og vertscelle som kan anvendes ved fremgangsmåten

Country Status (8)

Country	Link
EP (1)	EP0329671B1 (es)
JP (1)	JPH02501107A (es)
AU (1)	AU606627B2 (es)
DE (1)	DE3788806T2 (es)
ES (1)	ES2010230A6 (es)
HU (1)	HUT50875A (es)
NO (1)	NO177794C (es)
WO (1)	WO1988003562A1 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU3006789A (en) *	1988-02-24	1989-08-24	Smithkline Beckman Corporation	Expression of hiv binding proteins
US5631154A (en) *	1988-06-10	1997-05-20	Therion Biologics, Incorporated	Self assembled, defective, non-self-propagating lentivirus particles
US5747324A (en) *	1988-06-10	1998-05-05	Therion Biologics Corporation	Self-assembled, defective, non-self-propagating lentivirus particles
US5614404A (en) *	1988-06-10	1997-03-25	Theriod Biologics, Incorporated	Self-assembled, defective, non-self-propagating lentivirus particles
WO1994029459A1 (en)	1993-06-04	1994-12-22	Whitehead Institute For Biomedical Research	Stress proteins and uses therefor
ATE118247T1 (de) *	1988-09-27	1995-02-15	Dana Farber Cancer Inst Inc	Vektor, der ein replikationskompetentes hiv-i- provirus und ein heterologes gen enthält.
CA2003383A1 (en) *	1988-11-23	1990-05-23	Sushil G. Devare	Synthetic dna derived recombinant hiv antigens
WO1990005787A1 (en) *	1988-11-23	1990-05-31	The Regents Of The University Of California	Position-specific insertion vectors and method of using same
EP1288304A3 (en) *	1989-06-01	2006-04-05	Applied Biotechnology, Inc.	Self-assembled, defective, non-self-propagating viral particles
GB8923123D0 (en) *	1989-10-13	1989-11-29	Connaught Lab	A vaccine for human immunodeficiency virus
US5989886A (en) *	1991-01-02	1999-11-23	The Johns Hopkins University	Method for the inhibition and prevention of viral replication using fusions of a virus protein and a destructive enzyme
GB9107631D0 (en) *	1991-04-10	1991-05-29	British Bio Technology	Proteinaceous particles
EP0565794A1 (en) *	1992-04-14	1993-10-20	British Biotech Pharmaceuticals Limited	Induction of CTL responses
WO1994016084A1 (en) *	1993-01-16	1994-07-21	British Bio-Technology Limited	Hybrid particle-forming protein comprising a particle-inducing segment and a plurality of antigens
FR2703996B1 (fr) *	1993-04-16	1995-07-21	Transgene Sa	Ensemble de transposition destine au transfert d'un gene d'interet dans le genome d'une cellule eucaryote.
DE4335025A1 (de) *	1993-10-14	1995-04-20	Boehringer Ingelheim Int	Endosomolytisch wirksame Partikel
DE4405810A1 (de)	1994-02-23	1995-08-24	Behringwerke Ag	Von einem Retrovirus aus der HIV-Gruppe abgeleitete Peptide und deren Verwendung
US6525173B1 (en)	1997-01-02	2003-02-25	Universidade Federal De Minas Gerais	Process for expression and production of recombinant protein hybrid protein (p24/p17) derived from human immunodeficiency viruses (HIV-1)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GR76274B (es) *	1981-08-04	1984-08-04	Univ California
DE3788807T2 (de) *	1986-11-01	1994-06-30	British Bio Technology	Fusionsproteine und -partikel.

1987
- 1987-10-28 WO PCT/GB1987/000763 patent/WO1988003562A1/en not_active Ceased
- 1987-10-28 AU AU81534/87A patent/AU606627B2/en not_active Ceased
- 1987-10-28 EP EP87907014A patent/EP0329671B1/en not_active Expired - Lifetime
- 1987-10-28 JP JP62506486A patent/JPH02501107A/ja active Pending
- 1987-10-28 DE DE3788806T patent/DE3788806T2/de not_active Expired - Fee Related
- 1987-10-28 HU HU875702A patent/HUT50875A/hu unknown
- 1987-10-30 ES ES8703104A patent/ES2010230A6/es not_active Expired
1988
- 1988-06-30 NO NO882918A patent/NO177794C/no unknown

Also Published As

Publication number	Publication date
ES2010230A6 (es)	1989-11-01
EP0329671A1 (en)	1989-08-30
AU606627B2 (en)	1991-02-14
NO882918L (no)	1988-08-29
AU8153487A (en)	1988-06-01
DE3788806D1 (de)	1994-02-24
NO177794B (no)	1995-08-14
NO882918D0 (no)	1988-06-30
DE3788806T2 (de)	1994-07-07
HUT50875A (en)	1990-03-28
JPH02501107A (ja)	1990-04-19
EP0329671B1 (en)	1994-01-12
WO1988003562A1 (en)	1988-05-19

Similar Documents

Publication	Publication Date	Title
NO177793C (no)	1995-11-22	Fremgangsmåte for fremstilling av et fusjonsprotein, samt nukleinsyre, ekspresjonsvektor og vertscelle som kan anvendes ved fremgangsmåten
NO177794C (no)	1995-11-22	Fremgangsmåte for fremstilling av et fusjonsprotein, samt nukleinsyre, ekspresjonsvektor og vertscelle som kan anvendes ved fremgangsmåten
IT1119725B (it)	1986-03-10	Processo di rivelazione e di caratterizzazione di un acido nucleico o di una sua sequenza e reattivo enzimatico per la realizzazione di questo processo
NO175715C (no)	1994-11-23	Analogifremgangsmåte ved fremstilling av terapeutisk aktive aminosyrederivater, samt mellomprodukter ved fremstilling av disse
NO166230C (no)	1991-06-19	Fremgangsmaate for fraksjonering av plasmaproteiner i en opploesning av plasma ved hjelp av ionebyttere.
DK247084D0 (da)	1984-05-17	7-amino-1-cyclopropyl-6,8-difluor-1,4-dihydro-4-oxo-3-quinolincarboxylsyrer,fremgangsmaader til deres fremstilling samt antibakterielle midler indeholdende disse
DK110885A (da)	1985-09-13	Nucleinsyre-proteinkonjugater, disses anvendelse samt fremgangsmaade til fremstilling heraf
NO871785D0 (no)	1987-04-29	Fremgangsmaate for fremstilling av et proteinprodukt, samt vektorsystem for fremgangsmaatens utfoerelse.
FI883924A7 (fi)	1988-08-25	Menetelmä eukaryoottisten solujen aineenvaihdunnan modifioimiseksi nii hin sisällytettäessä nukleiinihappojen vieraita sekvenssejä sisällyttä vän vektorin avulla
DK374087A (da)	1988-01-19	Fremgangsmaade til fremstilling af proteiner med faktor viii-aktivitet ved hjaelp af mikrobielle voertsceller og ekspressionsvektorer, vaertsceller og antistoffer til anvendelse ved denne
FI880899L (fi)	1988-02-26	Oleellisesti puhdas DNA ja RNA ja menetelmä erytropoietiinin ekspressoimiseksi
NO964445L (no)	1996-10-18	DNA-sekvens, vektor, vertscelle og fremgangsmåte for transfeksjon av hematopoeseceller med eksogen DNA
NO178580C (no)	1996-04-24	Fremgangsmåte ved fremstilling av en bitumen-polymerblanding, samt anvendelse av denne og en stamopplösning for anvendelse ved fremstilling av bitumen-polymer-blandingen
NZ221790A (en)	1990-07-26	Method for the continuous production of a heterologous protein in a eukaryotic host cell
ATE158816T1 (de)	1997-10-15	Expression von pace in wirtszellen und verfahren zu dessen verwendung
DK388789D0 (da)	1989-08-08	Hybridderivat af humant protein d, dets fremstilling og anvendelse samt dna, som koder derfor, og genstruktur og vaertscelle indeholdende denne dna
IE840258L (en)	1984-08-07	Expression of gene products.
DK124787A (da)	1987-09-13	Peptider indeholdende op til 8-aminosyregrupperinger og fysiologisk uskadelige salte deraf, deres fremstilling og anvendelse som laegemidler samt mellemprodukter ved fremstillingen
DK170986A (da)	1986-10-23	Substituerede 2,3,4,9-tetrahydro-1h-carbazol-1-eddikesyre-derivater, deres fremstilling og anvendelse som famaceutika samt mellem-produkter ved fremstillingen
DK354188D0 (da)	1988-06-27	Guanidinothiazolforbindelse, fremgangsmaade til d eres fremstilling samt anvendelsen heraf som mellemprodukt i famotidinprocessen
FI850814A7 (fi)	1985-02-28	Proteiineja, farmaseuttisia seoksia, geenejä, vektoreita, isäntäorgan ismeja ja menetelmiä niiden tuottamiseksi.
PT90768A (pt)	1989-12-29	Processo para a preparacao de vectores de expressao e de proteinas nao fundidas usando esses vectores em microorganismos
AU6521186A (en)	1987-05-19	Lytic viruses as expression vectors, host cell containing same and process for protein production
NO178036C (no)	1996-01-10	Fremgangsmåte for fremstilling av fusjonsproteiner, genstruktur, vektorer streptomycetceller og fusjonsproteinene
DK172990A (da)	1990-07-19	Grf-peptid og praeparat indeholdende dette